BioAtla to monetize preclinical and clinical assets, cuts workforce ~70% in major restructuring
- Company initiates a formal process to monetize its preclinical and clinical assets
- Restructuring includes expanded cost-containment measures alongside approximately 70% workforce reduction
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.